Swedish biopharmaceutical company Sobi announced this week that beginning July 1 it will implement 340B contract pharmacy restrictions, making the [...] …
Category: Providers
340B hospitals need new transparency requirements and program eligibility rules to ensure the sustainability of the program, Republican lawmakers said [...] …
Generic and biosimilar drugmaker Sandoz recently added a drug used in conjunction with cancer treatments to its list of drugs [...] …
A major national 340B provider advocacy group is condemning the newly introduced 340B ACCESS Act, arguing that the proposed overhaul [...] …
A federal appeals court’s decision this week to uphold two drugmakers’ 340B contract pharmacy restrictions left unanswered questions about the [...] …
Medicare Part D beneficiaries who received retail and specialty drugs from prescribers at 340B disproportionate share hospitals (DSH) were more [...] …
Teva Pharmaceuticals recently added the 40th drug to the list of medications included in its contract pharmacy policy restrictions for [...] …
A federal appeals court today decided that the 340B statute does not prohibit drugmakers from placing conditions on the distribution [...] …
Shortly before adjourning, the Minnesota legislature cleared and sent to the governor legislation to bar 340B contract pharmacy access restrictions [...] …
Hospitals in the 340B program should respond to increasing drugmaker contract pharmacy restrictions by opening their own pharmacies or selectively [...] …